Free Trial

Smith & Nephew (SNN) Competitors

Smith & Nephew logo
$27.90 -0.24 (-0.84%)
Closing price 04/3/2025 03:59 PM Eastern
Extended Trading
$27.25 -0.65 (-2.31%)
As of 09:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, BLCO, INSP, and NARI

Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry.

Smith & Nephew vs.

Smith & Nephew (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment.

Smith & Nephew received 423 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. However, 61.90% of users gave GE HealthCare Technologies an outperform vote while only 54.29% of users gave Smith & Nephew an outperform vote.

CompanyUnderperformOutperform
Smith & NephewOutperform Votes
449
54.29%
Underperform Votes
378
45.71%
GE HealthCare TechnologiesOutperform Votes
26
61.90%
Underperform Votes
16
38.10%

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew$5.81B2.10$263M$2.1612.91
GE HealthCare Technologies$19.67B1.67$1.99B$4.3316.63

Smith & Nephew currently has a consensus target price of $27.00, suggesting a potential downside of 3.21%. GE HealthCare Technologies has a consensus target price of $97.73, suggesting a potential upside of 35.73%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
GE HealthCare Technologies
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, GE HealthCare Technologies had 31 more articles in the media than Smith & Nephew. MarketBeat recorded 35 mentions for GE HealthCare Technologies and 4 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 1.72 beat GE HealthCare Technologies' score of 1.18 indicating that Smith & Nephew is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
GE HealthCare Technologies
26 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

25.6% of Smith & Nephew shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.0% of Smith & Nephew shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

GE HealthCare Technologies has a net margin of 10.13% compared to Smith & Nephew's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Smith & Nephew's return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & NephewN/A N/A N/A
GE HealthCare Technologies 10.13%25.74%6.29%

Smith & Nephew has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500.

Smith & Nephew pays an annual dividend of $0.89 per share and has a dividend yield of 3.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew pays out 41.2% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

GE HealthCare Technologies beats Smith & Nephew on 16 of the 21 factors compared between the two stocks.

Remove Ads
Get Smith & Nephew News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNN vs. The Competition

MetricSmith & NephewSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$12.22B$8.86B$5.53B$18.94B
Dividend Yield3.17%1.42%4.86%3.78%
P/E Ratio12.9118.9423.2331.59
Price / Sales2.1071.93362.7525.45
Price / Cash8.0019.6738.1617.54
Price / Book2.344.946.494.36
Net Income$263M$284.66M$3.21B$1.02B
7 Day Performance-0.46%-4.87%-4.90%-3.87%
1 Month Performance-6.94%-7.95%-0.07%-4.82%
1 Year Performance14.61%-23.19%6.45%0.29%

Smith & Nephew Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNN
Smith & Nephew
2.928 of 5 stars
$27.90
-0.8%
$27.00
-3.2%
+13.3%$12.22B$5.81B12.9120,100
GEHC
GE HealthCare Technologies
4.102 of 5 stars
$80.71
+0.9%
$98.75
+22.4%
-19.1%$36.91B$19.67B18.6450,000Positive News
Gap Down
PHG
Koninklijke Philips
3.6227 of 5 stars
$25.40
-1.0%
N/A+16.7%$23.87B$18.02B-30.2378,200
ZBH
Zimmer Biomet
4.6871 of 5 stars
$113.33
+1.2%
$124.15
+9.5%
-13.3%$22.56B$7.68B25.4718,000Positive News
SOLV
Solventum
1.4129 of 5 stars
$76.02
+1.7%
$79.86
+5.0%
+10.2%$13.15B$8.25B27.6422,000Gap Down
PEN
Penumbra
4.3282 of 5 stars
$267.84
+0.1%
$294.47
+9.9%
+26.8%$10.32B$1.19B787.773,900Insider Trade
Analyst Revision
News Coverage
Gap Down
STVN
Stevanato Group
1.6672 of 5 stars
€20.37
+0.4%
N/A-32.6%$6.17B$1.10B43.344,650Positive News
GKOS
Glaukos
3.9413 of 5 stars
$98.49
-3.4%
$163.25
+65.8%
-7.9%$5.57B$383.48M-34.32780News Coverage
Positive News
Gap Down
BLCO
Bausch + Lomb
3.7937 of 5 stars
$14.50
+2.6%
$19.18
+32.3%
-21.4%$5.11B$4.79B-15.9312,500Analyst Forecast
News Coverage
High Trading Volume
INSP
Inspire Medical Systems
4.8505 of 5 stars
$159.60
+1.5%
$226.70
+42.0%
-29.0%$4.75B$802.80M92.261,246News Coverage
Positive News
NARI
Inari Medical
0.9868 of 5 stars
$79.97
flat
$68.00
-15.0%
N/A$4.68B$493.63M-59.24800
Remove Ads

Related Companies and Tools


This page (NYSE:SNN) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners